CLGN Collplant Biotechnologies Ltd 1631487 |
Balance Sheet |
Current Assets
|
20,335,000 |
Assets
|
26,566,000 |
Current Liabilities
|
3,241,000 |
Liabilities
|
5,837,000 |
Equity
|
20,729,000 |
Shares Out
|
11,455,000 |
Cash Flow Statement |
Operating Cash Flow
|
-7,181,000 |
Investing Cash Flow
|
-341,000 |
Market Analysis |
Market Cap
|
57,271,400 |
Price
|
4.03 |
BVPS
|
1.81 |
PB
|
2.24 |
EPS
|
-1.53 |
PS
|
115.00 |
FCF
|
-7,522,000 |
|
Earnings |
Apr |
May |
Jun |
4/04 |
|
5/29 |
-0.35 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CLGN documents filed with the SEC.
CLGN Filings
Clear